KLRK1: Characterizing A Transmembrane Protein Implicated in Many Diseases

Target Name: KLRK1

NCBI ID: G22914

KLRK1

KLRK1: Characterizing A Transmembrane Protein Implicated in Many Diseases

KLRK1 (Killer cell lectin like receptor K1) is a protein that is expressed in a variety of cell types, including blood cells, epithelial cells, and neural cells. It is a type of transmembrane protein that is characterized by the presence of a N- terminal extracellular domain, a catalytic domain, and a C-terminal transmembrane domain.

KLRK1 is involved in a variety of cellular processes, including cell adhesion, migration, and signaling. It is a key regulator of the immunological response, and has been implicated in the development and progression of many diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

Despite its importance, KLRK1 has not yet been fully characterized, and there is a need for further research to understand its functions and potential as a drug target. In this article, we will discuss the current understanding of KLRK1, its potential as a drug target. , and the research that has been done to study its effects.

The N-terminal extracellular domain of KLRK1 is involved in cell adhesion and migration. This domain contains a variety of conserved structural features that are involved in the formation of a complex with other proteins, including cadherins and integrins. These features include a N- terminal domain that is involved in the formation of a hydrophobic domain-protein interaction, a critical factor for protein-protein interactions and also for intracellular signaling.

The catalytic domain of KLRK1 is involved in the regulation of cellular processes such as cell adhesion, migration, and signaling. This domain contains a number of conserved structural features that are involved in the formation of a complex with other proteins, including cadherins and integrins . These features include a catalytic center that is involved in the regulation of protein-protein interactions and also in intracellular signaling.

The C-terminal transmembrane domain of KLRK1 is involved in the regulation of cellular processes such as cell adhesion, migration, and signaling. This domain contains a number of conserved structural features that are involved in the formation of a complex with other proteins, including cadherins and integrins. These features include a transmembrane region that is involved in the regulation of protein-protein interactions and also in intracellular signaling.

KLRK1 has been implicated in the development and progression of many diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. For example, studies have shown that KLRK1 is involved in the regulation of cancer cell migration and invasion. Additionally, KLRK1 has been shown to be involved in the regulation of neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease.

KLRK1 has also been shown to be involved in the regulation of autoimmune disorders, such as rheumatoid arthritis and multiple sclerosis. Studies have shown that KLRK1 is involved in the regulation of the immune response and in the development of autoimmune disorders.

Despite its importance, KLRK1 has not yet been fully characterized, and there is a need for further research to understand its functions and potential as a drug target. In the future, researchers will continue to study the role of KLRK1 in cellular processes and its potential as a drug target.

In conclusion, KLRK1 is a transmembrane protein that is involved in a variety of cellular processes, including cell adhesion, migration, and signaling. Its N-terminal, catalytic and C-terminal domains are involved in the regulation of cellular processes, including protein- protein interactions and intracellular signaling. KLRK1 has been implicated in the development and progression of many diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Further research is needed to understand its functions and potential as a drug target.

Protein Name: Killer Cell Lectin Like Receptor K1

The "KLRK1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about KLRK1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets